The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,250.00
Bid: 2,220.00
Ask: 2,280.00
Change: -40.00 (-1.75%)
Spread: 60.00 (2.703%)
Open: 2,275.00
High: 2,275.00
Low: 2,210.00
Prev. Close: 2,290.00
CRW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Options & Long Term Incentive Plan Awards

5 Sep 2018 12:20

RNS Number : 8726Z
Craneware plc
05 September 2018
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Options

&

Long Term Incentive Plan Awards

 

5 September 2018 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 5 September 2018, share options (the "Options") to acquire ordinary shares of 1p each in the Company ("Shares") were granted to two of the Company's Directors as set out below. The Options were granted pursuant to the terms of the Craneware plc Unapproved Share Option Plan (2016) (the "Option Plan").

 

Director

Aggregate no. of Shares over which Options granted under the Option Plan

Percentage of issued share capital

Keith Neilson (CEO)

5,848

0.02%

Craig Preston (CFO)

4,334

0.02%

 

The above Options have been granted at an exercise price of 2710p per Share (being the closing market price on 4 September 2018). The Options will ordinarily become exercisable from the third anniversary of grant, subject to (i) the satisfaction of certain performance conditions based on the Company's total shareholder return ("TSR") performance relative to the performance achieved by the constituent companies within the FTSE AIM 100 Index and (ii) the Director's continued employment. These performance conditions are measured in three tranches such that one third of the Shares over which the Options subsist will vest based on performance over the three years ending on 30 June 2019, one third based on performance over the three years ending 30 June 2020 and the final third based on performance over the three years to 30 June 2021 - an aggregate five year period. Any tranche (or part thereof) that does not meet the performance criteria will lapse and not be re-tested in later years.

 

The Company further announces that on 5 September 2018, under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), a conditional award of Shares was granted to two Directors of the Company as follows:

 

Director

No. of Shares over which a conditional share award was granted

Percentage of issued share capital

Keith Neilson (CEO)

5,848

0.02%

Craig Preston (CFO)

4,334

0.02%

 

There was no consideration for the grant of the LTIP awards and no consideration will be payable by the award holders to receive the Shares from these LTIP awards, if and to the extent that they vest. The awards will ordinarily vest after three years subject to (i) the satisfaction of TSR performance conditions that are substantively the same as those described above in relation to the Options and (ii) the Director's continued employment.

 

 

 

PDMR notification: Keith Neilson

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Keith Neilson

 

2. Reason for the notification

a) Position / status CEO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of share options under the Craneware plc Unapproved Share Option Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 5,848, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 5,848

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 5,848, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 5,848

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

PDMR notification: Craig Preston

 

1. Details of the Restricted Person / person closely associated with him or her

a) Name Craig Preston

 

2. Reason for the notification

a) Position / status CFO

b) Initial notification / Amendment Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name Craneware plc

b) LEI 213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of share options under the Craneware plc Unapproved Share Option Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 4,334, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 4,334

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code ISIN GB00B2425G68

 

c) Nature of the transaction Grant of conditional share award under the Craneware plc

Long Term Incentive Plan (2016)

 

d) Price(s) and volume(s) Volume(s) granted 4,334, Price(s) £0

 

e) Aggregated information:

i. Aggregated volume Aggregate volume granted 4,334

ii. Price Price(s) £0

 

f) Date of the transaction 2018-09-05

 

g) Place of the transaction Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt (NOMAD & Joint Broker)

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)208 004 4217

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Henry Reast

Robyn Fisher

Josh Royston

 

 

 

 

 

 

 

 

 

About Craneware

 

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSAFFIFASEFU
Date   Source Headline
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSExtension of share buyback programme
15th Apr 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20242:14 pmRNSDividend Currency Election
21st Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSInterim Results
17th Jan 20247:00 amRNSTrading Update and Notice of Results
14th Dec 20234:29 pmRNSNotification of Major Holdings
12th Dec 20232:36 pmRNSNotification of Major Holdings
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSDividend Currency Election
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20236:10 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Statement
1st Nov 20232:38 pmRNSExercise of SAYE Options, Director Dealing & TVR
25th Oct 20237:00 amRNSDirector Share Purchase
17th Oct 20236:10 pmRNSPosting of Annual Report and Notice of AGM
17th Oct 20239:44 amRNSExtension of share buyback programme
17th Oct 20237:00 amRNSTransaction in Own Shares
13th Oct 20237:00 amRNSBlock listing Interim Review
6th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
3rd Oct 20233:52 pmRNSVesting of Long Term Incentive Plan Awards
3rd Oct 20237:00 amRNSTransaction in Own Shares
29th Sep 20237:00 amRNSTransaction in Own Shares
28th Sep 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
7th Sep 20234:41 pmRNSExercise of Share Options
7th Sep 202310:04 amRNSGrant of Long Term Incentive Plan Awards
5th Sep 20237:00 amRNSFinal Results
1st Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.